Copyright © 2014 Justin A. Barterian et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Psychotropic medications are being prescribed off-label by psychiatrists to treat preschool children diagnosed with internalizing disorders. In this review, the current state of evidence is presented for medications used to treat preschool children (ages 2–5 year olds) diagnosed with anxiety and/or depressive disorders. Eleven studies were systematically identified for this review based on a priori criteria. Overall, the available literature revealed that studies addressing the medicati...
Although empirical evidence has recently validated clinical depression in children as young as age 3...
This article reviews the state of the science on psychosocial treatments for disruptive behaviors in...
Objective: To review the options for acute and maintenance pharmacological treatment of bipolar diso...
Psychotropic medications are being prescribed off-label by psychiatrists to treat preschool children...
Rates of prescriptions for very young children have increased notably in the last 20 years. These ch...
Objectives: Anxiety disorders are one of the most prevalent and underrecognized mental health disord...
Despite growing consensus that clinical interventions must be supported by empirical evidence, presc...
Background. The World Health Organization predicts that by 2030 internalising problems (e.g. depress...
Systematic research and practice guidelines addressing preschool psychopharmacological treatment in ...
Copyright: © 2014, Peyman Hashemian, et al., This is an open-access article distributed under the t...
(ABSTRACT) This study evaluated a treatment program for anxiety disordered children, ages five to tw...
This article reports results from an early intervention program aimed at preventing the development ...
Objective: This article reviews rational approaches to treating attention-deficit/hyperactivity diso...
Background- This study examined the effectiveness of an adaptation of an empirically-supported inte...
We aimed to identify promising novel medications for child and adolescent mental health problems. We...
Although empirical evidence has recently validated clinical depression in children as young as age 3...
This article reviews the state of the science on psychosocial treatments for disruptive behaviors in...
Objective: To review the options for acute and maintenance pharmacological treatment of bipolar diso...
Psychotropic medications are being prescribed off-label by psychiatrists to treat preschool children...
Rates of prescriptions for very young children have increased notably in the last 20 years. These ch...
Objectives: Anxiety disorders are one of the most prevalent and underrecognized mental health disord...
Despite growing consensus that clinical interventions must be supported by empirical evidence, presc...
Background. The World Health Organization predicts that by 2030 internalising problems (e.g. depress...
Systematic research and practice guidelines addressing preschool psychopharmacological treatment in ...
Copyright: © 2014, Peyman Hashemian, et al., This is an open-access article distributed under the t...
(ABSTRACT) This study evaluated a treatment program for anxiety disordered children, ages five to tw...
This article reports results from an early intervention program aimed at preventing the development ...
Objective: This article reviews rational approaches to treating attention-deficit/hyperactivity diso...
Background- This study examined the effectiveness of an adaptation of an empirically-supported inte...
We aimed to identify promising novel medications for child and adolescent mental health problems. We...
Although empirical evidence has recently validated clinical depression in children as young as age 3...
This article reviews the state of the science on psychosocial treatments for disruptive behaviors in...
Objective: To review the options for acute and maintenance pharmacological treatment of bipolar diso...